Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs111885088 | chr12:56657216 | A/C | 1.08E-7 | 177 | 25.35 | 26.37 | 0.8 | KM Plot |
PCPG | rs111899361 | chr7:1112348 | C/T | 0.000233 | 176 | 25.87 | 24.5 | 49.58 | KM Plot |
PCPG | rs111955762 | chr16:1664041 | T/C | 1.56E-11 | 173 | 25 | 30.25 | 4.52 | KM Plot |
PCPG | rs112034319 | chr21:38449248 | G/A | 5.33E-6 | 176 | 25 | 25.87 | 3.7 | KM Plot |
PCPG | rs11206673 | chr1:56326340 | C/T | 1.46E-6 | 178 | 17.93 | 16.6 | 27.2 | KM Plot |
PCPG | rs11206677 | chr1:56335237 | C/A | 2.0E-7 | 174 | 25.53 | 25.77 | 13.27 | KM Plot |
PCPG | rs112071133 | chr11:43424629 | TAAAG/T | 0.00025 | 175 | 25.08 | 24.97 | 27.6 | KM Plot |
PCPG | rs112071784 | chr8:140987876 | CTCAT/C | 1.11E-16 | 172 | 25.28 | 37.87 | 3.17 | KM Plot |
PCPG | rs112080769 | chr16:71816369 | A/AATT | 1.21E-5 | 173 | 24.47 | 30.93 | 14.5 | KM Plot |
PCPG | rs11211258 | chr1:46624627 | C/T | 0.000185 | 171 | 24.62 | 25.87 | 22.22 | KM Plot |
PCPG | rs112137398 | chr9:86644955 | C/T | 1.07E-5 | 173 | 26.22 | 23.83 | 10.3 | KM Plot |
PCPG | rs11214498 | chr11:112983622 | G/A | 0.000206 | 173 | 25.87 | 19.72 | 34.38 | KM Plot |
PCPG | rs11214499 | chr11:112983623 | A/C | 0.000206 | 173 | 25.87 | 19.72 | 34.38 | KM Plot |
PCPG | rs112154518 | chr2:241461061 | A/G | 5.73E-11 | 174 | 27.2 | 20.25 | 7.2 | KM Plot |
PCPG | rs112190984 | chr14:74457478 | T/G | 3.51E-6 | 177 | 25.17 | 30.93 | 10.3 | KM Plot |